Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral cephalexin and metronidazole to reduce cesarean section wound infection
IRCT20200608047685N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cefalexin and metronidazole in surgical site infection (SSI), sponsored by Mashhad University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
cefalexinmetronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20200608047685N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200608047685N2.